Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study

BACKGROUND: Some parenteral iron therapies have been found to be associated with hypophosphatemia. The mechanism of the decrease in serum phosphate is unknown. The aim of this study is to examine the effect of IV ferric carboxymaltose(FCM) on phosphate metabolism and FGF23 levels in patients with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Prats, Merche, Font, Ramon, García, Carmen, Cabré, Carmen, Jariod, Manel, Vea, Alberto Martinez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751040/
https://www.ncbi.nlm.nih.gov/pubmed/23902731
http://dx.doi.org/10.1186/1471-2369-14-167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751040/
https://www.ncbi.nlm.nih.gov/pubmed/23902731
http://dx.doi.org/10.1186/1471-2369-14-167

Ejemplares similares